ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 338477

Partial characterization of a T cell-derived factor that suppresses the initiation of the humoral immune response in vitro.

Douglas GN and 1 other. Immunology, 1977. Cited by 11 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Partial characterization of a T cell-derived factor that suppresses the initiation of the humoral immune response in vitro. Papers, record 338477. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/338477

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Partial characterization of a T cell-derived factor that suppresses the initiation of the humoral immune response in vitro.
PubMed
Journal
Immunology
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.31
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Douglas GNG N
2Rubin ASA S

Source PubMed

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibody FormationMajor topic
T-LymphocytesMajor topic
Animals
Antibody Specificity
B-Lymphocytes
Cells, Cultured
Chromatography, Gel
Deoxyribonucleases
Electrophoresis, Polyacrylamide Gel
Female
Hemolytic Plaque Technique
Hot Temperature
Kinetics
Mice
Mice, Inbred DBA
Molecular Weight
Peptide Hydrolases
Ribonucleases
Spleen

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1324,897Non-specific suppression of the initiation of the immune response to a heterologous immunogen by supernatants from specifically stimulated, primed lymphoid cells.Immunology1977https://conductscience.org/library/papers/324897PubMed
24,116,319The regulatory influence of activated T cells on B cell responses to antigen.Adv Immunol1972https://conductscience.org/library/papers/4116319PubMed
34,118,414Specific heterologous enhancement of immune responses. IV. Specific generation of a thymus-derived enhancing factor.J Exp Med1972https://conductscience.org/library/papers/4118414PubMed
44,122,709
Cell interactions between histoincompatible T and B lymphocytes. II. Failure of physiologic cooperative interactions between T and B lymphocytes from allogeneic donor strains in humoral response to hapten-protein conjugates.
J Exp Med1973https://conductscience.org/library/papers/4122709PubMed
54,128,811Soluble mediators of T-B interaction.Eur J Immunol1973https://conductscience.org/library/papers/4128811PubMed
64,405,567The allogeneic effect on immune responses: model for regulatory influences of T lymphocytes on the immune system.Transplant Rev1972https://conductscience.org/library/papers/4405567PubMed
74,277,751Unmasking and functional characterization of T-cell-replacing factors obtained from supernatants of allogeneic spleen cell mixtures.Scand J Immunol1974https://conductscience.org/library/papers/4277751PubMed
84,280,162Separation of murine lymphoid cells using nylon wool columns. Recovery of the B cell-enriched population.Transplantation1974https://conductscience.org/library/papers/4280162PubMed
94,583,072Specific heterologous enhancement of immune responses. V. Isolation of a soluble enhancing factor from supernatants of specifically stimulated and allogeneically induced lymphoid cells.J Immunol1973https://conductscience.org/library/papers/4583072PubMed
104,592,599Biological expressions of lymphocyte activation. 3. Suppression of plaque-forming cell responses in vitro by supernatant fluids from concanavalin A-activated spleen cell cultures.J Immunol1974https://conductscience.org/library/papers/4592599PubMed

1 to 10 of 26

See all 26 references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
6,975,236Further study on the humoral response of a highly-purified spleen-derived immunosuppressive peptide (SDIP).Immunology1981https://conductscience.org/library/papers/6975236PubMed
312,265Antagonistic interactions between enhancing and suppressor factors that regulate the humoral immune response.Immunology1979https://conductscience.org/library/papers/312265PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/338477

GET https://conductscience.org/api/papers/v1/338477/references?page=2

API referenceFor AI assistants